glp 1 binge eating disorder The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward GLP-1 and Eating Disorders: Risks

For most patients, the 14 beat per minute increase is not clinically significant and does not increase cardiovascular risk

Injection sites should be rotated weekly

In the early stages of HF, compensatory mechanisms reduce the impact of the cardiac dysfunction

In my kitchen, this is the week I would rather see someone eat six calm bites of something useful than push through a full plate that feels too heavy

D4H*-mCherry cell labelling and imaging INS-1 832/3 SNAP/FLAG-hGLP-1R WT or V229A cells were seeded onto 13-mm coverslips and labelled with SNAP-Surface 488 probe in full media for 20 minutes before stimulation with 100 nM exendin-4 for 2 minutes at 37C

Most side effects are manageable, but sometimes theyre bad enough to make people quit the meds.Doctors are still figuring out the long-term risks, especially as millions start using these drugs for weight loss instead of diabetes.People with certain thyroid problems, past endocrine cancers, or other underlying health concerns need to be extra careful and get medical supervision before starting GLP-1s